Nobilis Paramyxo P201 Emulsion for injection
Nobilis Paramyxo P201 Emulsion for injection
Authorised
- Pigeon paramyxovirus 1, strain P201, Inactivated
Product identification
Medicine name:
Nobilis Paramyxo P201 Emulsion for injection
Nobilis Paramyxo P201 Emulsie voor injectie
Nobilis Paramyxo P201 Emulsion injectable
Nobilis Paramyxo P201 Emulsion zur Injektion
Active substance:
- Pigeon paramyxovirus 1, strain P201, Inactivated
Target species:
-
Pigeon
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Pigeon paramyxovirus 1, strain P201, Inactivated6.80/log2 haemagglutination inhibiting unit(s)0.25millilitre(s)
Pharmaceutical form:
-
Emulsion for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Pigeon
-
Meat and offal0day
-
Egg0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01EA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- (ID3): 1 Box with 1 Bottle (PolyEthylene TerePhthalate) with 250 millilitre(s) (250 millilitre(s))
- (ID2): 1 Box with 1 Bottle (PolyEthylene TerePhthalate) with 50 millilitre(s) (50 millilitre(s))
- (ID1): 1 Box with 1 Bottle (PolyEthylene TerePhthalate) with 20 millilitre(s) (20 millilitre(s))
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V255744
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0219/001
Concerned member states:
-
Belgium
-
Denmark
-
France
-
Greece
-
Italy
-
Lithuania
-
Luxembourg
-
Netherlands
-
Portugal
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 28/01/2022
Updated on: 24/03/2023
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.